MedTrace Logo

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

NCT04671290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2020-12-17

No results posted yet for this study

Summary

To assess the efficacy of temocillin compared to carbapenems for the management of ESBL-E UTI.

Conditions

  • Urinary Tract Infection Bacterial

Interventions

OTHER

Any intervention

No intervention

Sponsors & Collaborators

  • APHP

    collaborator OTHER

  • Sorbonne University

    collaborator OTHER

  • Hopitaux Civils de Colmar

    collaborator OTHER

  • Hopital Foch

    collaborator OTHER

  • CH Annecy Genevois

    collaborator OTHER

  • Centre Hospitalier Annecy Genevois

    lead OTHER

Principal Investigators

  • Mathieu LAFAURIE, M.D · APHP, St Louis Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-10-31
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671290 on ClinicalTrials.gov